AbbVie (ABBV) Set to Acquire Apogee Therapeutics (APGE) for $11 Billion
AbbVie (ABBV) Set to Acquire Apogee Therapeutics (APGE) for $11 Billion GuruFocus
AbbVie (ABBV) Set to Acquire Apogee Therapeutics (APGE) for $11 Billion GuruFocus
Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.